2 hours ago
2
TipRanks
Sat, April 18, 2026 astatine 9:40 AM CDT 1 min read
Kailera Therapeutics (KLRA) priced 39.06M shares astatine $16.00. The woody size was accrued to 39.06M shares from 33.3M and priced astatine the precocious extremity of the $14.00-$16.00 range. JPMorgan, Jefferies, Leerink, TD Cowen and Evercore ISI are acting arsenic associated publication moving managers for the offering. Kailera is an precocious clinical-stage biotechnology institution that says it is “focused connected elevating the adjacent epoch of obesity care.”
-
Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
-
Discover top-performing banal ideas and upgrade to a portfolio of marketplace leaders with Smart Investor Picks
Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>
See the apical stocks recommended by analysts >>
Read More connected KLRA:
Disclaimer & DisclosureReport an Issue
-
Kailera Therapeutics 39.06M stock IPO priced astatine $16.00
English (CA) · 
English (US) · 
Spanish (MX) ·